It was recently revealed in a report that Egypt is being suspected to be the place where fake drugs are being manufactured these days. There are currently investigations underway to determine whether the fake Avastin drug packages were circulated in the market by a supplier from Egypt.
It was revealed by the medical regulator from the U. K. that there are currently efforts being made for being able to track the origin of the fake drugs that are currently plaguing the markets, which are an outright horror for patients as well as doctors.
It was revealed by a European wholesaler, who had also been involved in the circulation of the drug, that he didn’t know that the drug wasn’t real. It was revealed by CareMed ApS, from Denmark that there are changes going to be made in the orders of the country’s medical regulatory.
The maker of the drug, Avastin, Roche, had recently warned people and doctors that they need to be careful about the fake drugs available in the markets these days. They were of the view that this fake drug might be possibly contaminated and wouldn’t be able to help curing the disease, and would make situation more critical for the patients suffering from cancer.
In the same wake, the Food and Drug Administration has sent letters to make sure that the drug they are using is the original one and not a counterfeit.
"Caremed informed us last November that a customer of theirs noted differences in the batch numbers of delivered Avastin. Up till now Hadicon doesn't know whether this issue concerns Avastin delivered by Hadicon at all”, said Klaus-Rainer Toedter, Managing Director of Hadicon. It remains to be seen how soon the unscrupulous sources of the fake drug can be determined.
- A few Royals to get a sneak peek of the Chelsea Flower Show ahead of its public opening
- Nicki Minaj gives Lil Wayne a Lapdance at the 2013 Billboard Music Awards
- The Osbourne’s are re-united
- Rajinikanth’s Kochadaiyaan couldn’t make it to the Cannes Film Festival screening
- Combination Food of Soy and Tomato Can Probably Help in Prostate Cancer